Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 188

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 188
---
 days after such Form 25 -NSEis filed. Although we expect that we will be notified by Nasdaq prior to the filing of such Form 25 -NSE, as well as prior to the release of a press release by Nasdaq announcing the delisting event, we are not at this time able to determine when such Form 25 -NSEwill be filed or when the delisting of our securities from Nasdaq will be complete. We will announce the receipt of any correspondence from Nasdaq regarding the anticipated delisting event and/or the filing of such Form 25 -NSEpromptly upon receipt by us (and in all circumstances prior to the date of the Special Meeting) via the filing of a Current Report on Form 8 -K. Despite the anticipated delisting of our securities from Nasdaq, we intend to proceed with our efforts to consummate our initial Business Combination. However, Nasdaq approval of OmnigenicsAI’s initial listing application with respect to the Business Combination is a condition to such Business Combination, and there can be no guarantee that Nasdaq will approve such initial listing application, which may delay, or ultimately prevent the consummation of the proposed Business Combination. There can be no assurance that we will be able to satisfy Nasdaq’s initial listing requirements, or regain compliance with Nasdaq’s continued listing requirements, in a timely manner, or at all, and such delisting may delay, or ultimately prevent, the consummation of the Business Combination. In order to close the Business Combination, we will be required to demonstrate compliance with Nasdaq’s initial listing requirements, which are generally more rigorous than Nasdaq’s continued listing requirements. We believe that we will be able to evidence compliance with Nasdaq’s initial listing requirements (and therefore also necessarily regain compliance with respect to all applicable continued listing requirements) upon the consummation of the Business Combination, with such compliance being a condition to the consummation of the Business Combination. However, there can be no guarantee that we will be able to satisfy such initial listing requirements or continued listing requirements in a timely manner, or at all. Following the anticipated delisting of our securities from Nasdaq, we could become subject to the “penny stock” rules, the ability of our investors to sell our securities will likely be adversely impacted, and we may be unable to consummate the Business Combination in a timely manner, or at all, and would therefore be forced to liquidate. If we are forced to liquidate, our investors would not be able to realize the benefits of owning